SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Heiberg Hanne) "

Sökning: WFRF:(Heiberg Hanne)

  • Resultat 1-2 av 2
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Aidas, Kestutis, et al. (författare)
  • The Dalton quantum chemistry program system
  • 2014
  • Ingår i: Wiley Interdisciplinary Reviews. Computational Molecular Science. - : Wiley. - 1759-0876. ; 4:3, s. 269-284
  • Tidskriftsartikel (refereegranskat)abstract
    • Dalton is a powerful general-purpose program system for the study of molecular electronic structure at the Hartree-Fock, Kohn-Sham, multiconfigurational self-consistent-field, MOller-Plesset, configuration-interaction, and coupled-cluster levels of theory. Apart from the total energy, a wide variety of molecular properties may be calculated using these electronic-structure models. Molecular gradients and Hessians are available for geometry optimizations, molecular dynamics, and vibrational studies, whereas magnetic resonance and optical activity can be studied in a gauge-origin-invariant manner. Frequency-dependent molecular properties can be calculated using linear, quadratic, and cubic response theory. A large number of singlet and triplet perturbation operators are available for the study of one-, two-, and three-photon processes. Environmental effects may be included using various dielectric-medium and quantum-mechanics/molecular-mechanics models. Large molecules may be studied using linear-scaling and massively parallel algorithms. Dalton is distributed at no cost from for a number of UNIX platforms.
  •  
2.
  • Ostergaard, Mikkel, et al. (författare)
  • Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
  • 2023
  • Ingår i: Annals of the Rheumatic Diseases. - : BMJ PUBLISHING GROUP. - 0003-4967 .- 1468-2060. ; 82:10, s. 1286-1295
  • Tidskriftsartikel (refereegranskat)abstract
    • Background The optimal first-line treatment in early rheumatoid arthritis (RA) is debated. We compared clinical and radiographic outcomes of active conventional therapy with each of three biological treatments with different modes of action. Methods Investigator-initiated, randomised, blinded-assessor study. Patients with treatment-naive early RA with moderate-severe disease activity were randomised 1:1:1:1 to methotrexate combined with (1) active conventional therapy: oral prednisolone (tapered quickly, discontinued at week 36) or sulfasalazine, hydroxychloroquine and intra-articular glucocorticoid injections in swollen joints; (2) certolizumab pegol; (3) abatacept or (4) tocilizumab. Coprimary endpoints were week 48 Clinical Disease Activity Index (CDAI) remission (CDAI <= 2.8) and change in radiographic van der Heijde-modified Sharp Score, estimated using logistic regression and analysis of covariance, adjusted for sex, anticitrullinated protein antibody status and country. Bonferroni's and Dunnet's procedures adjusted for multiple testing (significance level: 0.025). Results Eight hundred and twelve patients were randomised. Adjusted CDAI remission rates at week 48 were: 59.3% (abatacept), 52.3% (certolizumab), 51.9% (tocilizumab) and 39.2% (active conventional therapy). Compared with active conventional therapy, CDAI remission rates were significantly higher for abatacept (adjusted difference +20.1%, p<0.001) and certolizumab (+13.1%, p=0.021), but not for tocilizumab (+12.7%, p=0.030). Key secondary clinical outcomes were consistently better in biological groups. Radiographic progression was low, without group differences. Conclusions Compared with active conventional therapy, clinical remission rates were superior for abatacept and certolizumab pegol, but not for tocilizumab. Radiographic progression was low and similar between treatments.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-2 av 2
Typ av publikation
tidskriftsartikel (2)
Typ av innehåll
refereegranskat (2)
Författare/redaktör
Ågren, Hans (1)
Ruud, Kenneth (1)
Lampa, Jon (1)
Nurmohamed, Michael ... (1)
Larsson, Per (1)
Vahtras, Olav (1)
visa fler...
Rinkevicius, Zilvina ... (1)
Norman, Patrick (1)
Kauczor, Joanna (1)
Aidas, Kestutis (1)
Kongsted, Jacob (1)
Nielsen, Christian B ... (1)
Mikkelsen, Kurt V. (1)
Christiansen, Ove (1)
Olsen, Jogvan Magnus ... (1)
Angeli, Celestino (1)
Bak, Keld L. (1)
Bakken, Vebjorn (1)
Bast, Radovan (1)
Boman, Linus (1)
Cimiraglia, Renzo (1)
Coriani, Sonia (1)
Dahle, Pal (1)
Dalskov, Erik K. (1)
Ekstrom, Ulf (1)
Enevoldsen, Thomas (1)
Eriksen, Janus J. (1)
Ettenhuber, Patrick (1)
Fernandez, Berta (1)
Ferrighi, Lara (1)
Fliegl, Heike (1)
Frediani, Luca (1)
Hald, Kasper (1)
Halkier, Asger (1)
Hattig, Christof (1)
Heiberg, Hanne (1)
Helgaker, Trygve (1)
Hennum, Alf Christia ... (1)
Hettema, Hinne (1)
Hjertenaes, Eirik (1)
Host, Stinne (1)
Hoyvik, Ida-Marie (1)
Iozzi, Maria Frances ... (1)
Jansik, Branislav (1)
Jensen, Hans Jorgen ... (1)
Jonsson, Dan (1)
Jorgensen, Poul (1)
Kirpekar, Sheela (1)
Kjrgaard, Thomas (1)
Klopper, Wim (1)
visa färre...
Lärosäte
Linköpings universitet (2)
Göteborgs universitet (1)
Kungliga Tekniska Högskolan (1)
Uppsala universitet (1)
Lunds universitet (1)
Karolinska Institutet (1)
Språk
Engelska (2)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (1)
Medicin och hälsovetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy